# Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis

> **NCT02845804** · — · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 1533 (estimated)

## Conditions studied

- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Acute Coronary Syndrome
- Angina Pectoris

## Interventions

- **DEVICE:** Alpine

## Key facts

- **NCT ID:** NCT02845804
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2018-07
- **Final completion:** 2021-07
- **Target enrollment:** 1533 (ESTIMATED)
- **Last updated:** 2016-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02845804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02845804, "Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02845804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*